Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating Factor

We administered recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) to four patients with myelodysplastic syndrome (MDS) and three patients with non‐MDS (two malignant lymphoma and one lung cancer) as a part of a phase II trial and analyzed the effects of rhG‐CSF on the neoplastic cell...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Jpn J Cancer Res
Hlavní autoři: Ohyashiki, Kazuma, Ohyashiki, Junko H., Toyama, Keisuke, Takaku, Fumimaro
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 1989
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5917852/
https://ncbi.nlm.nih.gov/pubmed/2480943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1989.tb01725.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky